Nature Pharma GLUCOlo+
Natural health product licensed in Canada
- Licence holder
- Groupe Nature Pharma Inc.
- NPN or DIN-HM
- 80087467
- Status
- Active licence
- Licence date
- 31 July 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Chrome: up to 500 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Zinc: up to 80 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Zinc: up to 80 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (25 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Momordica charantia Source : Fruit Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 200 mg | 10 mg | Not calculated |
| Magnésium Source : Sulfate de magnésium | 30 mg | 60,000 µg |
| Chrome Source : Picolinate de chrome (III) | 250 mcg | 500 µg |
| Zingiber officinale Source : Rhizome Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 550 mg | 55 mg | Not calculated |
| Trigonella foenum-graecum Source : Graine(s) Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 100 mg | 10 mg | Not calculated |
| Zinc Source : Oxyde de zinc | 40 mg | 80,000 µg |
| Thiamine Source : Chlorhydrate de thiamine | 50 mg | 100,000 µg |
| Cuivre Source : Citrate de cuivre (II) | 1,000 mcg | 2,000 µg |
| Panax quinquefolius Source : Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 100 mg | 10 mg | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Coenzyme Q10 | 50 mg | Not calculated |
| Cinnamomum aromaticum Source : Écorce (branche) Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,000 mg | 100 mg | Not calculated |
Non-medicinal ingredients
Gélatine, Stéarate de magnésium, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 2 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Provides support for healthy glucose metabolism. Helps the body to metabolize carbohydrates and fats. Helps to maintain healthy bones, hair, nail and/or skin. Helps to maintain immune function. Helps to maintain the body's ability to metabolize nutrients. Helps to form red blood cells. Helps to maintain normal iron transport in the body. Provides antioxidants. Helps to maintain and/or support cardiovascular health. (Clinically shown to) help(s) prevent nausea and vomiting associated with motion sickness, and/or seasickness. Ginger Traditionally used in Herbal Medicine to help relieve digestive upset/disturbances including lack of appetite, nausea, digestive spasms, indigestion, dyspepsia and flatulent colic (carminative). Ginger Traditionally used in Herbal Medicine as an expectorant and anti-tussive to help relieve bronchitis as well as coughs and colds.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80087467
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.